DULOXETINE ALEMBIC duloxetine (as hydrochloride) 60 mg enteric capsule blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

duloxetine hydrochloride, Quantity: 67.3 mg

Commercializzato da:

Alembic Pharmaceuticals Australia Pty Ltd

INN (Nome Internazionale):

Duloxetine hydrochloride

Forma farmaceutica:

Capsule, enteric

Composizione:

Excipient Ingredients: Gelatin; sucrose; hypromellose; triethyl citrate; purified talc; hypromellose phthalate; titanium dioxide; indigo carmine; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; Shellac; ethanol absolute; ammonia; potassium hydroxide; maize starch

Via di somministrazione:

Oral

Confezione:

28 capsules

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Duloxetine capsules are indicated for the treatment of major depressive disorder (MDD).,Treatment of Diabetic Peripheral Neuropathic Pain (DPNP). Treatment of Generalised Anxiety Disorder (GAD).

Dettagli prodotto:

Visual Identification: Opaque blue/opaque green hard gelatin capsule '158' on body and 'A' on cap with white ink; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2013-06-14